[go: up one dir, main page]

DE60121166D1 - 4-amino-1-hydroxybutyliden-1,1-biphosphonsäure enthaltende direktkomprimierte tablette - Google Patents

4-amino-1-hydroxybutyliden-1,1-biphosphonsäure enthaltende direktkomprimierte tablette

Info

Publication number
DE60121166D1
DE60121166D1 DE60121166T DE60121166T DE60121166D1 DE 60121166 D1 DE60121166 D1 DE 60121166D1 DE 60121166 T DE60121166 T DE 60121166T DE 60121166 T DE60121166 T DE 60121166T DE 60121166 D1 DE60121166 D1 DE 60121166D1
Authority
DE
Germany
Prior art keywords
hydroxybutylidene
amino
compressed tablet
directly compressed
acid directly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60121166T
Other languages
English (en)
Inventor
Dagmar Jasprova
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zentiva KS
Original Assignee
Zentiva KS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=5471285&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60121166(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zentiva KS filed Critical Zentiva KS
Application granted granted Critical
Publication of DE60121166D1 publication Critical patent/DE60121166D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60121166T 2000-07-11 2001-06-29 4-amino-1-hydroxybutyliden-1,1-biphosphonsäure enthaltende direktkomprimierte tablette Expired - Fee Related DE60121166D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20002567A CZ20002567A3 (cs) 2000-07-11 2000-07-11 Tableta vyrobitelná přímým tabletováním, obsahující aktivní látku kyselinu 4-amino-1-hydroxybutyliden-1,1-bisfosfonovou, a způsob její výroby
PCT/CZ2001/000037 WO2002003963A1 (en) 2000-07-11 2001-06-29 Tablet obtained by direct compression comprising 4-amino-1-hydroxybutylidene-1, 1-bisphosphonic acid as active ingredient

Publications (1)

Publication Number Publication Date
DE60121166D1 true DE60121166D1 (de) 2006-08-10

Family

ID=5471285

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60121166T Expired - Fee Related DE60121166D1 (de) 2000-07-11 2001-06-29 4-amino-1-hydroxybutyliden-1,1-biphosphonsäure enthaltende direktkomprimierte tablette

Country Status (17)

Country Link
US (1) US7198802B2 (de)
EP (1) EP1299088B1 (de)
AT (1) ATE331502T1 (de)
AU (1) AU2001270454A1 (de)
BG (1) BG107520A (de)
CA (1) CA2415630A1 (de)
CZ (1) CZ20002567A3 (de)
DE (1) DE60121166D1 (de)
EE (1) EE200300017A (de)
HR (1) HRP20020735A2 (de)
HU (1) HUP0301072A3 (de)
PL (1) PL360872A1 (de)
RU (1) RU2279273C2 (de)
SK (1) SK283249B6 (de)
UA (1) UA73784C2 (de)
WO (1) WO2002003963A1 (de)
YU (1) YU77702A (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6827718B2 (en) 2001-08-14 2004-12-07 Scimed Life Systems, Inc. Method of and apparatus for positioning and maintaining the position of endoscopic instruments
AU2003230805A1 (en) * 2002-04-05 2003-10-27 Penwest Pharmaceuticals Co. Sustained release metoprolol formulations
GR1004331B (el) * 2002-10-07 2003-09-05 Verisfield (Uk) Ltd Νεες φαρμακευτικες συνθεσεις που περιεχουν αλας αλενδρονικου οξεος
EP1781258A1 (de) * 2004-08-20 2007-05-09 Mepha AG Formulierungen von biphosphonaten
WO2006046100A1 (en) * 2004-10-25 2006-05-04 Ranbaxy Laboratories Limited Pharmaceutical composition of alendronic acid
WO2006054165A1 (en) * 2004-11-19 2006-05-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of alendronic acid and processes for their preparation
ES2507552T3 (es) * 2005-10-27 2014-10-15 Nexilis Ag Implante que contiene amino-bisfosfonatos y procedimiento para su producción
FR2918567B1 (fr) * 2007-07-11 2012-08-03 Pf Medicament Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
KR20110046555A (ko) * 2008-08-22 2011-05-04 욱크하르트 리서치 센터 레보도파, 카비도파 및 엔타카폰 또는 이의 염을 포함하는 단일 단위 경구 투여 약학 조성물
WO2010133629A1 (en) * 2009-05-19 2010-11-25 Grindeks, A Joint Stock Company Stable pharmaceutical composition of fludarabine phosphate
WO2011074961A1 (en) 2009-12-18 2011-06-23 Frieslandcampina Nederland Holding B.V. Co-processed tablet excipient composition its preparation and use
EP4392024A1 (de) 2021-08-25 2024-07-03 Basf Se Hilfszusammensetzung zur direkten tablettierung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5358941A (en) 1992-12-02 1994-10-25 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids with lactose
CA2162470C (en) * 1993-05-15 1998-06-16 Walter Preis Tablet with improved bioavailability containing dichloromethylenediphosphonic acid as the active substance
US5853759A (en) * 1996-05-17 1998-12-29 Merck & Co.. Inc. Effervescent alendronate formulation
CA2284705A1 (en) 1997-03-26 1998-10-01 Sepracor Inc. Chemically and thermally stable norastemizole formulations
AU2001240985B2 (en) * 2000-04-07 2005-08-04 Pfizer Products Inc. Estrogen agonist/antagonist metabolites

Also Published As

Publication number Publication date
EP1299088B1 (de) 2006-06-28
CZ289261B6 (cs) 2001-12-12
PL360872A1 (en) 2004-09-20
ATE331502T1 (de) 2006-07-15
US7198802B2 (en) 2007-04-03
YU77702A (sh) 2006-05-25
CZ20002567A3 (cs) 2001-12-12
WO2002003963A1 (en) 2002-01-17
RU2279273C2 (ru) 2006-07-10
BG107520A (bg) 2003-06-30
HUP0301072A3 (en) 2005-07-28
SK283249B6 (sk) 2003-04-01
HUP0301072A2 (hu) 2003-08-28
AU2001270454A1 (en) 2002-01-21
UA73784C2 (en) 2005-09-15
HRP20020735A2 (en) 2004-12-31
EP1299088A1 (de) 2003-04-09
US20030161878A1 (en) 2003-08-28
EE200300017A (et) 2004-10-15
CA2415630A1 (en) 2002-01-17
SK5112001A3 (en) 2002-02-05

Similar Documents

Publication Publication Date Title
RU95101048A (ru) Производные пролинамида, фармкомпозиция на их основе
TW200505406A (en) Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
DK0996429T3 (da) Faste opløsninger og faste dispersioner i vand tungtopløselige lægemidler
HRP20040996B1 (hr) Tablete visokog sadržaja lijeka
DE60142891D1 (de) Azetidinderivate enthaltende pharmazeutische zusammensetzungen, die azetidinderivate und deren herstellung
DE60121166D1 (de) 4-amino-1-hydroxybutyliden-1,1-biphosphonsäure enthaltende direktkomprimierte tablette
PE20001036A1 (es) Tabletas bioadhesivas para hidratacion progresiva y metodos para su elaboracion y uso
NZ507271A (en) Fast disintegrating tablets
WO2003037860A3 (en) Purine analogs having hsp90-inhibiting activity
JP2002511411A5 (de)
PT1379520E (pt) Antagonistas (nao-aril)-heterociclicos n-substituidos de nmda/nr2b
BR0015567A (pt) Compostos de ácido fenoxicarboxìlico e composições para liberar agentes ativos
EA200000584A3 (ru) Твердые фармацевтические композиции с контролируемым высвобождением, получаемые тепловым формованием
CR6682A (es) Inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorios, autoinmunes y respiratorias
NZ524138A (en) Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents
WO2002009719A1 (en) Antitumor agents
CA2326222A1 (en) Medicinal compositions
CR7074A (es) Derivados de mercaptoacetylamida y proceso para su preparacion y uso
NO20034863L (no) Deutererte 3-piperidinopropiofenon så vel som legemidler som inneholder disse forbindelser
BG106927A (en) Matrix tablet for prolonged release of trimetazidine after oral administration
CO5560515A2 (es) Combinacion de productos activos fungicidas
AU4249700A (en) Hydroxamic acid derivative
AU2002218746A1 (en) Composition comprising folic acid and zinc for improving male fertility
RU2003102448A (ru) Таблетка, получаемая непосредственным прессованием, содержащая 4-амино-1-гидроксибутилиден-1,1-бисфосфоновую кислоту в качестве активного ингредиента
DE60128100D1 (de) Analgetisches arzneimittel

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee